Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-04

FDA Approved: BELBUCA — Supplemental Application (BioDelivery Sciences International Inc)

View source ↗

Summary

The FDA approved a supplemental application for Belbuca (buprenorphine HCl buccal film) submitted by BioDelivery Sciences International, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BELBUCA (Buprenorphine hydrochloride)

Snippet

SUPPL AP for BELBUCA (BUPRENORPHINE HYDROCHLORIDE)